{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:41:41Z","timestamp":1777776101755,"version":"3.51.4"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Human immunodeficiency virus (HIV) is no longer considered a contraindication for kidney transplantation (KT). KT management in HIV patients is a complex process with challenges, such as drug interactions between immunosuppression and antiretroviral (ARV) therapy. In our country, no KT has been performed thus far in this category of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present the case of a 29-year-old female patient with HIV and end-stage renal disease (ESRD) who performed a KT from a related living donor in March 2022. KT immediate evolution was favorable. No transplant-related complications were reported. HIV viral load remained undetectable and CD4+ T cells were constantly &gt; 500 cell\/ \u03bcL, during the 18 months of follow-up. The main challenge in our case was the drug interaction between the protease inhibitor-based regimen and tacrolimus. This led to tacrolimus overdose, and, subsequently, change in ARV therapy. ARV switching was performed on a regimen based on integrase inhibitor and nucleoside reverse transcriptase inhibitors. After the ARV change, the therapeutic level of tacrolimus was easily reached and maintained. Kidney graft function remained normal during follow-up, despite tacrolimus overexposure, and no rejection or anti-HLA antibodies were observed. Another challenge was related to the donor's hepatitis C virus status (positive antibodies, negative nucleic acid test). The recipient did not develop seroconversion or detectable viremia at 3-, 6-, 12- and 18-months post-KT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We reported the first case of a successful KT in an ESRD patient with HIV in Romania, in whom the post-transplant evolution was favorable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/rjim-2024-0020","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T12:52:20Z","timestamp":1717764740000},"page":"362-368","source":"Crossref","is-referenced-by-count":1,"title":["HIV and kidney transplantation in Romania: The index case"],"prefix":"10.2478","volume":"62","author":[{"given":"Bogdan Marian","family":"Sorohan","sequence":"first","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Fundeni Clinical Institute , Department of Kidney Transplantation , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gener","family":"Ismail","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Fundeni Clinical Institute , Department of Nephrology , Bucharest Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Oprea","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Victor Babe\u0219 Clinical Hospital for Infectious and Tropical Diseases , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorina","family":"Tacu","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute , Department of Kidney Transplantation , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Fundeni Clinical Institute , Centre of Immunogenetics and Virology , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Domni\u0219or","sequence":"additional","affiliation":[{"name":"Fundeni Clinical Institute , Department 2 of Intensive Care Unit , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionu\u021b","family":"Manea","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Fundeni Clinical Institute , Department of Kidney Transplantation , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanel","family":"Sinescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Fundeni Clinical Institute , Department of Kidney Transplantation , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u0103t\u0103lin","family":"Baston","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy , Bucharest , Romania"},{"name":"Fundeni Clinical Institute , Department of Kidney Transplantation , Bucharest , Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"2026042914153718557_j_rjim-2024-0020_ref_001","unstructured":"UNAIDS [Internet]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_002","unstructured":"Compartimentul pentru Monitorizarea \u0219i Evaluarea infec\u021biei HIV\/SIDA \u00een Rom\u00e2nia (CNLAS). Infec\u021bia HIV\/SIDA \u00een Rom\u00e2nia, update 30 iunie 2022. 2022;1\u201331. Available from: https:\/\/www.cnlas.ro\/images\/doc\/30062022.pdf"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_003","doi-asserted-by":"crossref","unstructured":"MOCROFT A., KIRK O., GATELL J., REISS P., GARGALIANOS P., ZILMER K., et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007; 21(9):1119\u201327.","DOI":"10.1097\/QAD.0b013e3280f774ee"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_004","doi-asserted-by":"crossref","unstructured":"ACHHRA AC., MOCROFT A., ROSS MJ., RYOM L., LUCAS GM., FURRER H., et al. Kidney disease in antiretroviral-na\u00efve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015; 16 Suppl 1(0 1):55\u201363.","DOI":"10.1111\/hiv.12234"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_005","doi-asserted-by":"crossref","unstructured":"FABIAN J., NAICKER S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol. 2009;5(10):591\u20138.","DOI":"10.1038\/nrneph.2009.141"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_006","doi-asserted-by":"crossref","unstructured":"RAZZAK CHAUDHARY S., WORKENEH BT., MONTEZ-RATHME., ZOLPA AR., KLOTMAN PE., WINKELMAYER WC. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant . 2015; 30(10):1734\u201340.","DOI":"10.1093\/ndt\/gfv207"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_007","doi-asserted-by":"crossref","unstructured":"WONG C., GANGE SJ., BUCHACZ K., MOORE RD., JUSTICE AC., HORBERG MA., et al. First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clin Infect Dis . 2017;64(4):459\u201367.","DOI":"10.1093\/cid\/ciw804"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_008","doi-asserted-by":"crossref","unstructured":"KUDOSE S., SANTORIELLO D., BOMBACK AS., STOKES MB., BATAL I., MARKOWITZ GS., et al. The spectrum of kidney biopsy findings in HIV-infected patients in the modern era. Kidney Int. 2020;97(5):1006\u201316.","DOI":"10.1016\/j.kint.2020.01.018"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_009","doi-asserted-by":"crossref","unstructured":"LOCKE JE., GUSTAFSON S., MEHTA S., REED RD., SHELTON B., MACLENNAN PA., et al. Survival Benefit of Kidney Transplantation in HIV-infected Patients. Ann Surg. 2017;265(3):604\u20138.","DOI":"10.1097\/SLA.0000000000001761"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_010","doi-asserted-by":"crossref","unstructured":"LEE DH., BOYLE SM., MALAT GE., KERN C., MILROD C., DEBELLIS S., et al. Barriers to listing for HIV-infected patients being evaluated for kidney transplantation. Transpl Infect Dis . 2017;19(6).","DOI":"10.1111\/tid.12777"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_011","doi-asserted-by":"crossref","unstructured":"TOURRET J., GUIGUET M., LASSALLE M., GRABAR S., LI\u00c8VRE L., ISNARD-BAGNIS C., et al. Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study. Am J Transplant . 2019;19(12):3345\u201355.","DOI":"10.1111\/ajt.15500"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_012","doi-asserted-by":"crossref","unstructured":"LOCKE JE., MEHTA S., SAWINSKI D., GUSTAFSON S., SHELTON BA., REED RD., et al. Access to Kidney Transplantation among HIV-Infected Waitlist Candidates. Clin J Am Soc Nephrol. 2017;12(3):467\u201375.","DOI":"10.2215\/CJN.07460716"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_013","doi-asserted-by":"crossref","unstructured":"SAWINSKI D. Kidney Transplantation in Patients with HIV. Kidney360. 2020;1(7):705\u201311.","DOI":"10.34067\/KID.0002112020"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_014","doi-asserted-by":"crossref","unstructured":"SOROHAN BM., ISMAIL G., LECA N. Immunosuppression in HIV-positive kidney transplant recipients. Curr Opin Organ Transplant. 2023;28(4):279\u201389.","DOI":"10.1097\/MOT.0000000000001076"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_015","doi-asserted-by":"crossref","unstructured":"VAN MAARSEVEEN EM., ROGERS CC., TROFE-CLARK J., VAN ZUILEN AD., MUDRIKOVA T. Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: A review. AIDS Patient Care STDS. 2012;26(10):568\u201381.","DOI":"10.1089\/apc.2012.0169"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_016","doi-asserted-by":"crossref","unstructured":"VAN MAARSEVEEN EM., CROMMELIN HA., MUDRIKOVA T., VAN DEN BROEK MPH., VAN ZUILEN AD. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: A pilot study. Transplantation. 2013;95(2):397\u2013402.","DOI":"10.1097\/TP.0b013e3182734651"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_017","doi-asserted-by":"crossref","unstructured":"COOPER M., DUNNE I., KUTEN S., CURTIS A., GRAVISS EA., NGUYEN DT., et al. Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients. Transplant Proc. 2021;53(3):984\u20138.","DOI":"10.1016\/j.transproceed.2020.10.003"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_018","doi-asserted-by":"crossref","unstructured":"ROLLINS B., FAROUK S., DEBOCCARDO G., LERNER S., RANA M., HUPRIKAR S., et al. Higher rates of rejection in HIV-infected kidney transplant recipients on ritonavir-boosted protease inhibitors: 3-year follow-up study. Clin Transplant. 2019;33(6):e13534.","DOI":"10.1111\/ctr.13534"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_019","doi-asserted-by":"crossref","unstructured":"DE VERA ME., VOLK ML., NCUBE Z., BLAIS S., ROBINSON M., ALLEN N., et al. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia. Am J Transplant . 2018;18(10):2451\u20136.","DOI":"10.1111\/ajt.15031"},{"key":"2026042914153718557_j_rjim-2024-0020_ref_020","doi-asserted-by":"crossref","unstructured":"DAO A., CUFFY M., KAISER TE., LOETHEN A., CAFARDI J., LUCKETT K., et al. Use of HCV Ab+\/NAT- donors in HCV na\u00efve renal transplant recipients to expand the kidney donor pool. Clin Transplant. 2019;33(7):e13598.","DOI":"10.1111\/ctr.13598"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2024-0020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:20:36Z","timestamp":1777486836000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2024-0020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6,7]]},"published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["10.2478\/rjim-2024-0020"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2024-0020","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}